Toronto Dominion Bank’s Bristol-Myers Squibb BMY Stock Holding History

Toronto Dominion Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,300	Closed	-$1.26M	–	1940
2025 Q2	$1.26M	Buy	+27,300	New	+$1.34M	﹤0.01%	1068
2019 Q4	–	Sell	-35,000	Closed	-$1.77M	–	1361
2019 Q3	$1.77M	Buy	35,000 +400	+1%	+$18.8K	﹤0.01%	857
2019 Q2	$786K	Sell	34,600 -173,400	-83%	-$8.08M	﹤0.01%	1012
2019 Q1	$9.92M	Buy	208,000 +202,500	+3,682%	+$10.1M	0.02%	500
2018 Q4	$286K	Sell	5,500 -53,900	-91%	-$2.9M	﹤0.01%	1071
2018 Q3	$3.69M	Buy	+59,400	New	+$3.53M	0.01%	725

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank's BMY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, selling an estimated $25.1M and leaving 909,773 shares worth $55.2M. The position accounts for 0.08% of the portfolio, ranked #222.

Toronto Dominion Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $146M in Q4 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Toronto Dominion Bank held 909,773 shares of Bristol-Myers Squibb worth $55.2M as of Q1 2026.
Toronto Dominion Bank sold 430,738 Bristol-Myers Squibb shares in Q1 2026, an estimated $25.1M.
Bristol-Myers Squibb made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #222 holding.
Toronto Dominion Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's Bristol-Myers Squibb position peaked at $146M in Q4 2019.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.